(Q37968179)

26 August 2017

title

Erythropoietin produced by the retina: its role in physiology and diabetic retinopathy (English)

1 reference

26 August 2017

1 reference

0 references

Cristina Hernández

1

1 reference

26 August 2017

Rafael Simó

series ordinal

2

1 reference

26 August 2017

publication date

14 December 2011

1 reference

26 August 2017

1 reference

26 August 2017

volume

41

1 reference

26 August 2017

issue

2

1 reference

26 August 2017

page(s)

220-226

1 reference

https://scigraph.springernature.com/pub.10.1007/s12020-011-9579-6

26 August 2017

exact match

0 references

cites work

Role of the kidney in erythropoiesis

1 reference

https://api.crossref.org/works/10.1007%2FS12020-011-9579-6

Erythropoietin production by interstitial cells of hypoxic monkey kidneys

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-011-9579-6

Isolation and characterization of genomic and cDNA clones of human erythropoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-011-9579-6

Erythropoietin: a novel neuroprotective cytokine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-011-9579-6

Landmark advances in the development of erythropoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-011-9579-6

Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-011-9579-6

Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-011-9579-6

Erythropoietin reduces myocardial infarction and left ventricular functional decline after coronary artery ligation in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-011-9579-6

Intracardiac injection of erythropoietin induces stem cell recruitment and improves cardiac functions in a rat myocardial infarction model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-011-9579-6

Erythropoietin receptor mRNA expression in human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-011-9579-6

Erythropoietin and hypoxia stimulate erythropoietin receptor and nitric oxide production by endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-011-9579-6

EPO tecting the endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-011-9579-6

Erythropoietin after a century of research: younger than ever

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-011-9579-6

Control of erythropoietin gene expression and its use in medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-011-9579-6

The signal transduction pathway of erythropoietin involves three forms of mitogen-activated protein (MAP) kinase in UT7 erythroleukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-011-9579-6

Interleukin-3, Erythropoietin, and Prolactin Activate a STAT5-like Factor in Lymphoid Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-011-9579-6

Erythropoietin receptors that signal through Stat5 or Stat3 support fetal liver and adult erythropoiesis: lack of specificity of stat signals during red blood cell development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-011-9579-6

Cytokine receptor signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-011-9579-6

Interaction of the erythropoietin and stem-cell-factor receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-011-9579-6

Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-011-9579-6

Cardioprotection by a nonerythropoietic, tissue-protective peptide mimicking the 3D structure of erythropoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-011-9579-6

Erythropoietin-mediated tissue protection: reducing collateral damage from the primary injury response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-011-9579-6

Erythropoietin and the hypoxic brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-011-9579-6

Expression of erythropoietin and its receptor in the human retina: a comparative study of diabetic and nondiabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-011-9579-6

Effects of erythropoietin on brain function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-011-9579-6

Erythropoietin--an endogenous retinal survival factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-011-9579-6

Neuroprotection of photoreceptors by direct delivery of erythropoietin to the retina of the retinal degeneration slow mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-011-9579-6

ERK- and Akt-dependent neuroprotection by erythropoietin (EPO) against glyoxal-AGEs via modulation of Bcl-xL, Bax, and BAD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-011-9579-6

Erythropoietin protects the in vitro blood-brain barrier against VEGF-induced permeability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-011-9579-6

Erythropoietin prevents the increase in blood-brain barrier permeability during pentylentetrazol induced seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-011-9579-6

Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-011-9579-6

Neuroprotective role of erythropoietin by antiapoptosis in the retina.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-011-9579-6

Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-011-9579-6

Erythropoietin and VEGF exhibit equal angiogenic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-011-9579-6

Vitreous levels of erythropoietin in patients with macular oedema secondary to retinal vein occlusions: a comparative study with diabetic macular oedema

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-011-9579-6

Glycosylation of erythropoietin affects receptor binding kinetics: role of electrostatic interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-011-9579-6

Cellular trafficking and degradation of erythropoietin and novel erythropoiesis stimulating protein (NESP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-011-9579-6

Erythropoietin administration protects retinal neurons from acute ischemia-reperfusion injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-011-9579-6

HIF-1-induced erythropoietin in the hypoxic retina protects against light-induced retinal degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-011-9579-6

Intravitreal administration of erythropoietin and preservation of retinal ganglion cells in an experimental rat model of glaucoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-011-9579-6

Neuronal death in primary retinal cultures is related to nitric oxide production, and is inhibited by erythropoietin in a glucose-sensitive manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-011-9579-6

Intravitreal injection of erythropoietin protects both retinal vascular and neuronal cells in early diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-011-9579-6

Erythropoietin protects retinal pigment epithelial cells against the increase of permeability induced by diabetic conditions: essential role of JAK2/ PI3K signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-011-9579-6

Erythropoietin attenuated high glucose-induced apoptosis in cultured human aortic endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-011-9579-6

Epo protects SOD2-deficient mouse astrocytes from damage by oxidative stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-011-9579-6

Nonerythropoietic, tissue-protective peptides derived from the tertiary structure of erythropoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-011-9579-6

Intervention with an erythropoietin-derived peptide protects against neuroglial and vascular degeneration during diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-011-9579-6

New techniques for drug delivery to the posterior eye segment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-011-9579-6

Experimental and clinical evidence for brimonidine as an optic nerve and retinal neuroprotective agent: an evidence-based review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-011-9579-6

Experimental and clinical evidence of neuroprotection by nerve growth factor eye drops: Implications for glaucoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-011-9579-6

Alpha2 adrenergic modulation of NMDA receptor function as a major mechanism of RGC protection in experimental glaucoma and retinal excitotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-011-9579-6

Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-011-9579-6

Tyrosine 343 in the erythropoietin receptor positively regulates erythropoietin-induced cell proliferation and Stat5 activation.

21 January 2018

1 reference

12 December 2020

Purification of human erythropoietin

1 reference

12 December 2020

Effects of glucose on growth, metabolism and EPO expression in recombinant CHO cell cultures

1 reference

12 December 2020

A central role for inflammation in the pathogenesis of diabetic retinopathy

1 reference

12 December 2020

Activation of the mitogen-activated protein kinase pathway by the erythropoietin receptor.

1 reference

12 December 2020

Interleukin 2 and erythropoietin activate STAT5/MGF via distinct pathways

1 reference

12 December 2020

Proinflammatory cytokines lowering erythropoietin production

1 reference

12 December 2020

Erythropoietin: physiology and pharmacology update

1 reference

12 December 2020

Studies on the production of erythropoietin by isolated perfused organs

1 reference

12 December 2020

EPO reduces reactive gliosis and stimulates neurotrophin expression in Muller cells.

1 reference

12 December 2020

Localization of erythropoietin synthesizing cells in murine kidneys by in situ hybridization

1 reference

12 December 2020

Erythropoietin deficiency decreases vascular stability in mice.

1 reference

12 December 2020

Localization of cells producing erythropoietin in murine liver by in situ hybridization

1 reference

12 December 2020

Erythropoietin receptor positive circulating progenitor cells and endothelial progenitor cells in patients with different stages of diabetic retinopathy

1 reference

12 December 2020

Human erythropoietin induces a pro-angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo

1 reference

12 December 2020

Erythropoietin: when liability becomes asset in neurovascular repair

1 reference

12 December 2020

Long-term Treatment with Suberythropoietic Epo is Vaso- and Neuroprotective in Experimental Diabetic Retinopathy

1 reference

12 December 2020

Liver as the primary site of erythropoietin formation in the fetus

1 reference

12 December 2020

Treating azotemia-induced anemia with erythropoietin improves diabetic eye disease

1 reference

12 December 2020

Targeting intraocular neovascularization and edema--one drop at a time

1 reference

12 December 2020

The production of an erythropoietic factor by the in situ perfused kidney

1 reference

12 December 2020

Erythropoietin is expressed in the human retina and it is highly elevated in the vitreous fluid of patients with diabetic macular edema

1 reference

12 December 2020

Erythropoietin is highly elevated in vitreous fluid of patients with proliferative diabetic retinopathy

1 reference

12 December 2020

In vitro production of erythropoietin by kidneys perfused with a serum-free solution

1 reference

12 December 2020

Erythropoietin induces the tyrosine phosphorylation, nuclear translocation, and DNA binding of STAT1 and STAT5 in erythroid cells

1 reference

12 December 2020

10.1007/S12020-011-9579-6

Identifiers

DOI

1 reference

26 August 2017

1 reference